Question 1

What is the analyst consensus rating for KRYS?

Accepted Answer

The analyst consensus rating for KRYS is "Strong Buy" based on 5 analyst recommendations.

Question 2

What is the average price target for KRYS?

Accepted Answer

The average 12-month price target for KRYS is $319.40, representing an upside of 11.0% from the current price of $287.84.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Feb 2, 2026	Andrea Tan	Goldman Sachs	Maintains	Strong Buy	$206.00 → $327.00 +121.00 (58.7%)
Jan 22, 2026	Alec Stranahan	BofA Securities	Maintains	Strong Buy	$288.00 → $318.00 +30.00 (10.4%)
Jan 12, 2026	Yigal Nochomovitz	Citi	Maintains	Strong Buy	$320.00 → $336.00 +16.00 (5.0%)
Jan 9, 2026	Joseph Pantginis	HC Wainwright	Reiterates	Strong Buy	$240.00 → $310.00 +70.00 (29.2%)
Jan 9, 2026	Ritu Baral	TD Cowen	Maintains	Strong Buy	$202.00 → $306.00 +104.00 (51.5%)
Jan 9, 2026	Yigal Nochomovitz	Citi	Maintains	Strong Buy	$309.00 → $320.00 +11.00 (3.6%)
Jan 6, 2026	Yigal Nochomovitz	Citi	Upgrades	Strong Buy	$198.00 → $309.00 +111.00 (56.1%)

Krystal Biotech (KRYS) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest KRYS Analyst Ratings & Recommendations